Consistent with miR-205 inhibitors, overexpressed CDK2AP1 significantly decreased the proliferation ability of HCC cells at 48 and 72 h, compared with control group (Fig. 3b). The gene discussed is CDK2AP1; the disease is hepatocellular carcinoma.